Ultralife Corporation (ULBI)
NASDAQ: ULBI · Real-Time Price · USD
6.55
+0.12 (1.87%)
Mar 23, 2026, 4:00 PM EDT - Market closed
Ultralife Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Ultralife in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Ultralife.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +113.74% | Nov 15, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +113.74% | Jun 27, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +98.47% | Mar 5, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +83.21% | Aug 8, 2023 |
| Benchmark | Benchmark | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +83.21% | Mar 26, 2021 |
Financial Forecast
Revenue This Year
229.40M
from 191.16M
Increased by 20.00%
Revenue Next Year
n/a
from 229.40M
EPS This Year
0.95
from -0.35
EPS Next Year
n/a
from 0.95
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 |
|---|---|
| High | 236.2M |
| Avg | 229.4M |
| Low | 220.4M |
Revenue Growth
| Revenue Growth | 2026 |
|---|---|
| High | 23.5% |
| Avg | 20.0% |
| Low | 15.3% |
EPS Forecast
| EPS | 2026 |
|---|---|
| High | 0.98 |
| Avg | 0.95 |
| Low | 0.91 |
EPS Growth
| EPS Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.